Ulcerative colitis triggered by pegylated interferon alone therapy for chronic hepatitis C
Akif Altınbas MD
Department of Gastroenterology, Dıskapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorFulya Koybasıoglu MD
Department of Pathology, Dıskapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorElif Aktas MD
Department of Radiology, Dr. Abdurrahman Yurtaslan Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorBarıs Yılmaz MD
Department of Gastroenterology, Dıskapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorSahin Coban MD
Department of Gastroenterology, Dıskapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorAkif Altınbas MD
Department of Gastroenterology, Dıskapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorFulya Koybasıoglu MD
Department of Pathology, Dıskapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorElif Aktas MD
Department of Radiology, Dr. Abdurrahman Yurtaslan Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorBarıs Yılmaz MD
Department of Gastroenterology, Dıskapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorSahin Coban MD
Department of Gastroenterology, Dıskapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey
Search for more papers by this author
REFERENCES
- 1 Seow CH, Benchimol EI, Griffiths AM, et al. Type I interferons for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2008: CD006790.
- 2 Sumer N, Palabiyikglu M. Induction of remission by interferonalpha in patients with chronic active ulcerative colitis. Eur J Gastroenterol Hepatol. 1995; 7: 597–602.
- 3 Musch E, Andus T, Malek M. Induction and maintenance of clinical remission by interferon-beta in patients with steroidrefractory active ulcerative colitis — an open long-term pilot trial. Aliment Pharmacol Ther. 2002; 16: 1233–1239.
- 4 Tursi A. Rapid onset of ulcerative colitis after treatment with PEGinterferon plus ribavirin for chronic hepatitis C. Inflamm Bowel Dis. 2007; 13: 1189–1190.
- 5 Watanabe T, Inoue M, Harada K, et al. A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin. Gut. 2006; 55: 1682–1683.
- 6 Sprenger R, Sagmeister M, Offner F. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis. Gut. 2005; 54: 438–439.
- 7 Mavrogiannis C, Papanikolaou IS, Elefsiniotis IS, et al. Ulcerative colitis associated with interferon treatment for chronic hepatitis C. J Hepatol. 2001; 34: 964–5.
- 8 Bargiggia S, Thorburn D, Anderloni A, et al. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study. Aliment Pharmacol Ther. 2005; 22: 209–15.
